ARCHIVES

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

August 7, 1987

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986